Home > News > Heiner Dreismann Joins Nanogen Board
October 31st, 2006
Heiner Dreismann Joins Nanogen Board
Nanogen, Inc. (Nasdaq:NGEN), developer of advanced diagnostic products, announced today that
Heiner Dreismann, Ph.D. has been named to its Board of Directors.
Dreismann, currently CEO of FasTraQ, Inc., has more than 20 years
experience with Roche in the biotech and healthcare industry, most recently
as president and CEO of Roche Molecular Systems.
Researchers from Deakin and Drexel develop super-absorbent material to soak up oil spills November 30th, 2015
New study reveals what's behind a tarantula's blue hue: Researchers uncover nanostructures in exoskeleton of blue-haired tarantulas November 30th, 2015
Tiny octopods catalyze bright ideas: Rice-led study shows plasmonic sensors and catalysts need not be mutually exclusive November 30th, 2015
Coming to a monitor near you: A defect-free, molecule-thick film November 29th, 2015
Kerstin Kleese van Dam Named Director of Brookhaven Lab's Computational Science Initiative September 26th, 2015
QD Vision Names Display Industry Veteran Mustafa Ozgen as CEO to Support Aggressive Growth and Market Expansion September 15th, 2015
National Space Society Welcomes Janet Ivey As New NSS Governor: Janet Ivey of Janet's Planet is NOW IN ORBIT as a member of the Board of Governors of the National Space Society August 27th, 2015
National Space Society Welcomes Geoff Notkin As New NSS Governor August 26th, 2015